Emergence of Multidrug- and Pandrug- Resistant Pseudomonas aeruginosa from Five Hospitals in Qatar [PDF]
Infection Prevention in Practice, 2019 Summary: Background: A global rise in multidrug-resistant (MDR) nosocomial infections has led to a significant increase in morbidity and mortality. MDR Gram-negative bacteria (GNB) are recognised for rapidly developing drug resistance.
M.A. Sid Ahmed +15 more
doaj +4 more sources
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria [PDF]
BMC Infectious Diseases, 2005 Background The increasing problem of infections due to multidrug-resistant Gram-negative bacteria has led to re-use of polymyxins in several countries.
Bliziotis Ioannis A +5 more
doaj +3 more sources
Draft Genome Sequences of Pandrug-Resistant Serratia marcescens Clinical Isolates Harboring bla NDM-1 [PDF]
Genome Announcements, 2017 The draft genome sequences of two clonal, pandrug-resistant Serratia marcescens clinical isolates were determined. The resistance phenotype was plasmid driven, as 14 of 17 resistance genes were present on large IncFIB(K), IncHI2, and IncA/C2 plasmids ...
Chakraborty, Trinad +6 more
core +6 more sources
Asian Journal of Medical Sciences, 2013 Pandrug resistant Pseudomonas keratitis is an emerging cause of bacterial keratitis challenging clinicians for prompt and prudent treatment to avoid disaster of loss of eye.
Munesh K Gupta
doaj +3 more sources
Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis [PDF]
Global Health Action, 2019 Background The majority of existing studies aimed at investigating the incidence and prevalence of multidrug-resistance by bacteria have been performed in healthcare settings.
Nana Adoma Nkansa-Gyamfi +3 more
doaj +2 more sources
Pandrug-Resistant Acinetobacter baumannii Causing Nosocomial Infections in a University Hospital, Taiwan [PDF]
Emerging Infectious Diseases, 2002 The rapid emergence (from 0% before 1998 to 6.5% in 2000) of pandrug-resistant Acinetobacter baumannii (PDRAB) was noted in a university hospital in Taiwan.
Po-Ren Hsueh +5 more
doaj +3 more sources
Molecular Assessment of MCR-1 Gene among Pandrug-Resistant Acinetobacter baumannii
Microbiology Research, 2023 Background Antimicrobial resistance has become one of the most widespread threats to humans. Acinetobacter baumannii is one of the pathogens responsible for healthcare-associated infections (nosocomial).
Shaimaa S. Sobieh +3 more
doaj +2 more sources
Risk Factors and Clinical Characteristics of Pandrug-Resistant Pseudomonas aeruginosa. [PDF]
CureusThe emergence of increasingly resistant strains of Pseudomonas aeruginosa is a great public health concern. Understanding the risk factors and clinical characteristics of patients with pandrug-resistant P. aeruginosa (PDR-PA) can help inform clinicians in creating guidelines for both prevention and management.
Kamal S +5 more
europepmc +3 more sources
Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients [PDF]
Antibiotics, 2022 Helen Giamarellou, Ilias Karaiskos
exaly +2 more sources
Antibiotics, 2022 The increasing consumption of broad-spectrum antimicrobials is fuelling a vicious cycle leading to extensively drug-resistant (XDR) and pandrug-resistant (PDR) bacteria [...]
Stamatis Karakonstantis +1 more
doaj +1 more source